Test blood/heart signals to understand atrial fibrillation changes
Part of Heart & circulation clinical trials.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and able to give consent
- Speak English and be able to take part in digital follow-up
- Have AF (atrial fibrillation/flutter) or be having a related heart procedure (ablation/cardioversion/EP study)
- If you have a past history of AF, it must be “non-valvular” and not from a reversible cause
- Not be on chronic anti-arrhythmia medicines (if you’re in the AF history group)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different computer “analysis methods” that look at real-time heart recordings from people with atrial fibrillation. It may help improve how atrial fibrillation is evaluated during/after an ablation procedure.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study looks at blood-related “clotting” signs and heart scan results in people with atrial fibrillation (AF) who are getting a catheter ablation. It may help doctors better understand AF and choose treatments more precisely.
This study looks at patients who have both atrial fibrillation (irregular heartbeats) and heart failure. It aims to predict health outcomes for people who are having a procedure called ablation, which aims to restore a normal heart rhythm. Participating could help doctors understand who might benefit most from this treatment.
This study is a registry that collects information from patients with atrial fibrillation who are having an ablation procedure. It aims to improve care and research by tracking outcomes. You may be able to join if you are scheduled for an ablation, and some participants may be asked to take part in additional optional sub-studies.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.